Restart of anticoagulant therapy and risk of thrombosis, rebleeding, and death after factor Xa inhibitor reversal in major bleeding patients - Milling, T J, Jr; King, B; Yue, P; ANNEXA-4 Investigators (Thromb Haemost, 2021)